Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis

Clin Vaccine Immunol. 2015 Jun;22(6):664-71. doi: 10.1128/CVI.00078-15. Epub 2015 Apr 29.

Abstract

A large community outbreak of Q fever occurred in the Netherlands in the period 2007 to 2010. Some of the infected patients developed chronic Q fever, which typically includes pathogen dissemination to predisposed cardiovascular sites, with potentially fatal consequences. To identify the immune mechanisms responsible for ineffective clearance of Coxiella burnetii in patients who developed chronic Q fever, we compared serum concentrations of 47 inflammation-associated markers among patients with acute Q fever, vascular chronic Q fever, and past resolved Q fever. Serum levels of gamma interferon were strongly increased in acute but not in vascular chronic Q fever patients, compared to past resolved Q fever patients. Interleukin-18 levels showed a comparable increase in acute as well as vascular chronic Q fever patients. Additionally, vascular chronic Q fever patients had lower serum levels of gamma interferon-inducible protein 10 (IP-10) and transforming growth factor β (TGF-β) than did acute Q fever patients. Serum responses for these and other markers indicate that type I immune responses to C. burnetii are affected in chronic Q fever patients. This may be attributed to an affected immune system in cardiovascular patients, which enables local C. burnetii replication at affected cardiovascular sites.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chemokine CXCL10 / blood
  • Female
  • Humans
  • Interferon-gamma / blood*
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Q Fever / epidemiology
  • Q Fever / immunology*
  • Q Fever / pathology*
  • Retrospective Studies
  • Serum / chemistry*
  • Transforming Growth Factor beta / blood
  • Young Adult

Substances

  • CXCL10 protein, human
  • Chemokine CXCL10
  • Transforming Growth Factor beta
  • Interferon-gamma